This case study examines the presentation, diagnosis, and management of Mr. Arthur Jenkins, a 68-year-old male admitted to St. Jude's Hospital with a three-week history of progressive fatigue, reduced appetite, and noticeable swelling in his lower extremities. Mr. Jenkins’ initial presentation was characterized by significant edema extending to his mid-shin and a complaint of shortness of breath, particularly upon exertion. These symptoms prompted a thorough medical evaluation to ascertain the underlying cause of his deteriorating renal function.
Upon admission, Mr. Jenkins’ vital signs were stable, though his blood pressure was elevated at 175/95 mmHg. Laboratory investigations revealed severe renal impairment. His serum creatinine was 6.2 mg/dL (baseline unknown, but significantly elevated from typical values of 0.6-1.2 mg/dL), with a corresponding blood urea nitrogen (BUN) of 85 mg/dL. Urinalysis showed significant proteinuria (3+), microscopic hematuria, and granular casts, indicative of intrinsic renal pathology. A complete blood count showed mild anemia (hemoglobin 10.5 g/dL), consistent with chronic kidney disease. Electrolyte levels indicated hyperkalemia (6.8 mEq/L) and hyperphosphatemia (5.5 mg/dL), posing immediate management challenges.
The differential diagnosis at this stage included various causes of acute kidney injury (AKI) superimposed on potential chronic kidney disease (CKD). Given the presence of proteinuria, hematuria, and granular casts, glomerulonephritis was a strong consideration. Further investigations, including serological tests for autoimmune markers such as antinuclear antibodies (ANA) and anti-double-stranded DNA (anti-dsDNA), were ordered. Renal ultrasound revealed kidneys that were echogenic and reduced in size (approximately 9.5 cm each), suggesting chronic changes rather than purely acute damage. A renal biopsy was performed to definitively establish the etiology and guide treatment.
The renal biopsy results confirmed a diagnosis of IgA nephropathy, a common form of glomerulonephritis characterized by the deposition of IgA antibodies in the glomeruli. This finding explained the proteinuria, hematuria, and progressive decline in kidney function. Based on the biopsy and clinical presentation, Mr. Jenkins' management plan was initiated. Immediate goals were to stabilize his electrolyte imbalances, control his hypertension, and mitigate further renal damage.
In the acute phase, Mr. Jenkins was placed on a low-sodium (2-gram daily) and low-potassium diet. Intravenous fluids were administered cautiously to manage fluid overload and improve renal perfusion. Hyperkalemia was addressed with a combination of oral potassium binders (sodium polystyrene sulfonate) and dietary restriction. Hypertension was managed with an ACE inhibitor (lisinopril) and a calcium channel blocker (amlodipine). With these interventions, his serum potassium levels gradually normalized, and his blood pressure improved.
For the underlying IgA nephropathy, a course of high-dose corticosteroids (prednisone 1 mg/kg) was initiated to reduce inflammation in the glomeruli. This immunosuppressive therapy was planned for an initial period of six months, with gradual tapering based on his response and tolerance. The goals were to reduce proteinuria and preserve remaining renal function. Supportive care also included phosphate binders (calcium acetate) to manage hyperphosphatemia and erythropoiesis-stimulating agents (ESAs) to address his anemia.
Over the subsequent six months, Mr. Jenkins showed a significant improvement. His serum creatinine stabilized at 3.5 mg/dL, and his proteinuria decreased to 1+. His blood pressure remained well-controlled within the target range of 130-140/80-90 mmHg. He reported a substantial increase in energy levels and resolution of lower extremity edema. The corticosteroid dose was successfully tapered, and he was transitioned to a maintenance regimen. Regular follow-up appointments, including periodic laboratory checks and urinalysis, were scheduled to monitor his renal function and manage any potential long-term complications of IgA nephropathy and its treatment. This case highlights the importance of a systematic approach to diagnosing and managing complex renal conditions.